Immu能叫预测吗
Avadel Pharmaceuticals Announces Positive Topline Results from its Pivotal Phase 3 REST-ON Trial of Once-Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy
恭喜持有的朋友们!我们的估值模型给了价格区间,大家可以分享,看看我们模型的准确度如何。网页链接
@淘沙见金 @飞冲天 @书呆老李 @Efficacious @Replix锐璞-Yang @美股医药Z博士 @药师老庙 @跑江糊